|
Steph, I believe the study is taking volunteers who are currently on Herceptin monotherapy:
"Phase II Study of a HER-2/neu (HER2) Intracellular Domain (ICD) Peptide-based Vaccine Administered to Stage IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab Monotherapy".
Let us know what Andrea says!
Love, Lolly
|